JP2014527082A5 - - Google Patents

Download PDF

Info

Publication number
JP2014527082A5
JP2014527082A5 JP2014530756A JP2014530756A JP2014527082A5 JP 2014527082 A5 JP2014527082 A5 JP 2014527082A5 JP 2014530756 A JP2014530756 A JP 2014530756A JP 2014530756 A JP2014530756 A JP 2014530756A JP 2014527082 A5 JP2014527082 A5 JP 2014527082A5
Authority
JP
Japan
Prior art keywords
phenyl
amino
hal
ethyl
piperazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014530756A
Other languages
English (en)
Japanese (ja)
Other versions
JP6082011B2 (ja
JP2014527082A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/054877 external-priority patent/WO2013040044A1/en
Publication of JP2014527082A publication Critical patent/JP2014527082A/ja
Publication of JP2014527082A5 publication Critical patent/JP2014527082A5/ja
Application granted granted Critical
Publication of JP6082011B2 publication Critical patent/JP6082011B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014530756A 2011-09-12 2012-09-12 キナーゼ活性のモジュレーターとして使用するためのアミノピリミジン誘導体 Expired - Fee Related JP6082011B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161533606P 2011-09-12 2011-09-12
US61/533,606 2011-09-12
PCT/US2012/054877 WO2013040044A1 (en) 2011-09-12 2012-09-12 Aminopyrimidine derivatives for use as modulators of kinase activity

Publications (3)

Publication Number Publication Date
JP2014527082A JP2014527082A (ja) 2014-10-09
JP2014527082A5 true JP2014527082A5 (enExample) 2016-09-29
JP6082011B2 JP6082011B2 (ja) 2017-02-15

Family

ID=46964039

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014530756A Expired - Fee Related JP6082011B2 (ja) 2011-09-12 2012-09-12 キナーゼ活性のモジュレーターとして使用するためのアミノピリミジン誘導体

Country Status (24)

Country Link
US (3) US9321760B2 (enExample)
EP (1) EP2755958B9 (enExample)
JP (1) JP6082011B2 (enExample)
KR (1) KR101992505B1 (enExample)
CN (2) CN106946796B (enExample)
AU (2) AU2012308681B2 (enExample)
BR (1) BR112014005468A2 (enExample)
CA (1) CA2844704C (enExample)
DK (1) DK2755958T3 (enExample)
EA (1) EA028057B1 (enExample)
ES (1) ES2646759T3 (enExample)
HR (1) HRP20171655T1 (enExample)
HU (1) HUE034979T2 (enExample)
IL (2) IL231381B (enExample)
LT (1) LT2755958T (enExample)
MX (1) MX347241B (enExample)
NO (1) NO2639780T3 (enExample)
PL (1) PL2755958T3 (enExample)
PT (1) PT2755958T (enExample)
RS (1) RS56486B1 (enExample)
SG (1) SG2014009260A (enExample)
SI (1) SI2755958T1 (enExample)
WO (1) WO2013040044A1 (enExample)
ZA (1) ZA201401007B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9073947B2 (en) 2011-06-10 2015-07-07 Merck Patent Gmbh Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
ES2646759T3 (es) * 2011-09-12 2017-12-15 Merck Patent Gmbh Derivados de aminopirimidina para uso como moduladores de la actividad de la quinasa
AR093512A1 (es) 2012-11-16 2015-06-10 Merck Patent Gmbh Derivados heterociclicos como moduladores de la actividad de cinasas
MX370448B (es) 2013-03-11 2019-12-13 Merck Patent Gmbh Derivados de 6- [4- (1h-imidazol-2-il) piperidin-1-il] pirimidin-4-amina como moduladores de la actividad de cinasa.
WO2015107494A1 (en) 2014-01-17 2015-07-23 Novartis Ag 1 -(triazin-3-yi_/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions thereof for inhibiting the activity of shp2
ES2699351T3 (es) 2014-01-17 2019-02-08 Novartis Ag Derivados de 1-piridazin/triazin-3-il-piper(-azina)/idina/pirolidina y composiciones de las mismas para inhibir la actividad de SHP2
JO3517B1 (ar) 2014-01-17 2020-07-05 Novartis Ag ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
JP6560243B2 (ja) * 2014-02-11 2019-08-14 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung キナーゼ活性のモジュレーターとしてのピリミジンイミダゾールアミン
EP3420792B1 (en) 2014-04-30 2021-09-22 LG Electronics Inc. Lawn mower robot and control method thereof
KR102518994B1 (ko) * 2014-05-28 2023-04-05 아스트라제네카 아베 Azd5363의 제조 방법 및 그에 사용되는 신규 중간체
WO2016203406A1 (en) 2015-06-19 2016-12-22 Novartis Ag Compounds and compositions for inhibiting the activity of shp2
ES2824576T3 (es) 2015-06-19 2021-05-12 Novartis Ag Compuestos y composiciones para inhibir la actividad de SHP2
EP3310779B1 (en) 2015-06-19 2019-05-08 Novartis AG Compounds and compositions for inhibiting the activity of shp2
US10829484B2 (en) 2015-07-28 2020-11-10 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
US10160747B2 (en) * 2016-03-16 2018-12-25 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
PT3468972T (pt) 2016-06-14 2020-08-21 Novartis Ag Compostos e composições para inibir a atividade da shp2
CN110730678B (zh) 2017-01-10 2022-07-15 诺华股份有限公司 包含alk抑制剂和shp2抑制剂的药物组合
CN109467538A (zh) 2017-09-07 2019-03-15 和记黄埔医药(上海)有限公司 环烯烃取代的杂芳环类化合物及其用途
WO2019084395A1 (en) 2017-10-27 2019-05-02 University Of Virginia Patent Foundation COMPOUNDS AND METHODS FOR REGULATING, LIMITING OR INHIBITING AVIL EXPRESSION
WO2020223715A1 (en) * 2019-05-02 2020-11-05 University Of Virginia Patent Foundation Substituted (piperidin-1-yl)aryl analogues for modulating avilactivity
US11866421B2 (en) * 2021-05-31 2024-01-09 Epigen Biosciences, Inc. Pyrimidine and pyridine amine compounds and usage thereof in disease treatment
CN116903592B (zh) * 2023-07-13 2025-08-01 特科罗生物科技(成都)有限公司 一种嘧啶胺类nuak抑制剂及其制备方法和用途

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137755A1 (en) * 2000-12-04 2002-09-26 Bilodeau Mark T. Tyrosine kinase inhibitors
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
US7547794B2 (en) 2003-04-03 2009-06-16 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
US7189729B2 (en) 2003-09-30 2007-03-13 Irm Llc Methods and compositions as protein kinase inhibitors
US7816353B2 (en) 2003-10-24 2010-10-19 Exelixis, Inc. P70S6 kinase modulators and method of use
RU2006121646A (ru) 2003-11-21 2008-01-10 Новартис АГ (CH) Производные 1h-имидазохинолина в качестве ингибиторов протеинкиназы
AU2004293026B2 (en) * 2003-11-21 2012-01-19 Array Biopharma Inc. AKT protein kinase inhibitors
BRPI0417498A (pt) 2003-12-09 2007-05-29 Us Gov Health & Human Serv método para suprimir uma resposta imune em um indivìduo; método de inibição da proliferação de um célula; método de tratamento de um distúrbio proliferativo em um indivìduo; método para selecionar um agente imunossupressor ou anti-proliferativo; composição farmacêutica e estente vascular
WO2005117909A2 (en) 2004-04-23 2005-12-15 Exelixis, Inc. Kinase modulators and methods of use
AU2005322085B2 (en) * 2004-12-28 2012-07-19 Exelixis, Inc. [1H-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70S6K, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
EP1838703A2 (en) 2005-01-19 2007-10-03 Neurogen Corporation Heteroaryl substituted piperazinyl-pyridine analogues
GB0501999D0 (en) 2005-02-01 2005-03-09 Sentinel Oncology Ltd Pharmaceutical compounds
US8343953B2 (en) 2005-06-22 2013-01-01 Astex Therapeutics Limited Pharmaceutical compounds
WO2007125321A2 (en) * 2006-04-25 2007-11-08 Astex Therapeutics Limited Purine and deazapurine derivatives as pharmaceutical compounds
WO2008012635A2 (en) * 2006-07-26 2008-01-31 Pfizer Products Inc. Amine derivatives useful as anticancer agents
EP2131656A4 (en) * 2006-11-15 2011-12-07 Forest Lab Holdings Ltd phthalazine
JP2010513458A (ja) * 2006-12-19 2010-04-30 ファイザー・プロダクツ・インク H−pgdsの阻害剤としてのニコチンアミド誘導体、およびプロスタグランジンd2の仲介による疾患を治療するためのその使用
UA99284C2 (ru) 2007-05-11 2012-08-10 Елі Ліллі Енд Компані ИНГИБИТОРЫ р70 S6-КИНАЗЫ
AR074072A1 (es) 2008-11-11 2010-12-22 Lilly Co Eli Compuesto de imidazol -piperidin -pirrol-pirimidin-6-ona, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar el glioblastoma multiforme
KR101699991B1 (ko) 2009-02-11 2017-01-26 메르크 파텐트 게엠베하 신규의 아미노 아자헤테로시클릭 카르복사미드
WO2011029043A1 (en) * 2009-09-04 2011-03-10 Biogen Idec Ma Inc. Heteroaryl btk inhibitors
UA110113C2 (xx) 2010-07-29 2015-11-25 Біциклічні азагетероциклічні карбоксаміди
US9586938B2 (en) 2010-07-29 2017-03-07 Merck Patent Gmbh Cyclic amine azaheterocyclic carboxamides
EA023821B1 (ru) 2010-11-24 2016-07-29 Мерк Патент Гмбх Хиназолинкарбоксамидазетидины, их применение в лечении гиперпролиферативных заболеваний и содержащие их композиции
HRP20171554T1 (hr) * 2011-09-12 2017-11-17 Merck Patent Gmbh Novi imidazol amini kao modulatori aktivnosti kinaze
ES2646759T3 (es) * 2011-09-12 2017-12-15 Merck Patent Gmbh Derivados de aminopirimidina para uso como moduladores de la actividad de la quinasa
AR093511A1 (es) * 2012-11-16 2015-06-10 Merck Patent Gmbh Derivados de imidazol-piperidinilo como moduladores de la actividad de cinasas
JP6560243B2 (ja) * 2014-02-11 2019-08-14 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung キナーゼ活性のモジュレーターとしてのピリミジンイミダゾールアミン

Similar Documents

Publication Publication Date Title
HRP20171655T1 (hr) Derivati aminopirimidina za upotrebu kao modulatori aktivnosti kinaze
CN114430740A (zh) Egfr抑制剂、组合物及其制备方法
JP2022520448A5 (enExample)
JP2016513660A5 (enExample)
US9199979B2 (en) Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors
CN114430739A (zh) Egfr抑制剂、组合物及其制备方法
JP2014520898A5 (enExample)
JP2016525078A5 (enExample)
JP2022520811A5 (enExample)
JP2020503297A5 (enExample)
RU2012151012A (ru) Циклопропиловые дикарбоксамиды и аналоги, обладающие противораковым и антипролиферативным действием
JP2014531436A5 (enExample)
JP2019517487A5 (enExample)
JP2021516232A5 (enExample)
RU2010150786A (ru) Пирролопиридины как ингибиторы киназы
IL291590B2 (en) Novel substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereof
JP2008528467A5 (enExample)
JP2012507566A5 (enExample)
RU2015122414A (ru) Соединения n-пирролидинилмочевины, n'-пиразолилмочевины, тиомочевины, гуанидина и цианогуанидина как ингибиторы киназы trka
JP2016522246A5 (enExample)
JP2009526072A5 (enExample)
JP2023536164A5 (enExample)
JP2017525757A5 (enExample)
JP2013522292A5 (enExample)
JP2016509583A5 (enExample)